DrugPatentWatch Database Preview
Alcon Labs Inc Company Profile
» See Plans and Pricing
What is the competitive landscape for ALCON LABS INC, and when can generic versions of ALCON LABS INC drugs launch?
ALCON LABS INC has twelve approved drugs.
There are two US patents protecting ALCON LABS INC drugs.
There are thirty patent family members on ALCON LABS INC drugs in nineteen countries and one supplementary protection certificate in one country.
Summary for Alcon Labs Inc
| International Patents: | 30 |
| US Patents: | 2 |
| Tradenames: | 9 |
| Ingredients: | 8 |
| NDAs: | 12 |
Drugs and US Patents for Alcon Labs Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon Labs Inc | PATADAY ONCE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 206276-001 | Jan 30, 2015 | OTC | Yes | Yes | 9,533,053 | Start Trial | Y | Start Trial | |||
| Alcon Labs Inc | CYCLOGYL | cyclopentolate hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 084109-001 | Approved Prior to Jan 1, 1982 | AT | RX | No | Yes | Start Trial | Start Trial | ||||
| Alcon Labs Inc | FLUORESCITE | fluorescein sodium | INJECTABLE;INTRAVENOUS | 021980-001 | Mar 28, 2006 | AP | RX | Yes | Yes | Start Trial | Start Trial | ||||
| Alcon Labs Inc | ISOPTO ATROPINE | atropine sulfate | SOLUTION/DROPS;OPHTHALMIC | 208151-001 | Dec 1, 2016 | RX | Yes | Yes | Start Trial | Start Trial | |||||
| Alcon Labs Inc | CYCLOGYL | cyclopentolate hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 084108-001 | Approved Prior to Jan 1, 1982 | RX | No | Yes | Start Trial | Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Alcon Labs Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Alcon Labs Inc | PATADAY ONCE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 021545-001 | Dec 22, 2004 | 5,116,863*PED | Start Trial |
| Alcon Labs Inc | PATADAY TWICE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 020688-001 | Dec 18, 1996 | 4,923,892 | Start Trial |
| Alcon Labs Inc | PATADAY TWICE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 020688-001 | Dec 18, 1996 | 5,641,805*PED | Start Trial |
| Alcon Labs Inc | PATADAY ONCE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 021545-001 | Dec 22, 2004 | 5,641,805*PED | Start Trial |
| Alcon Labs Inc | PATADAY TWICE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 020688-001 | Dec 18, 1996 | 4,871,865 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Alcon Labs Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| South Korea | 20140009332 | Start Trial |
| South Korea | 101821518 | Start Trial |
| Ukraine | 114597 | Start Trial |
| Japan | 2014515355 | Start Trial |
| European Patent Office | 2709610 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Alcon Labs Inc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0799044 | 02C0040 | France | Start Trial | PRODUCT NAME: OLOPATADINE HYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/02/217/001 20020517 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
